易方达中证创新药产业ETF联接发起式A(019666)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-24,792,583.29 |
-11,093,624.52 |
13,577,521.72 |
-2,904,363.43 |
| 利息合计 |
66,553.32 |
44,752.98 |
10,100.24 |
6,510.95 |
| 其中：存款利息收入 |
66,553.32 |
44,752.98 |
10,100.24 |
6,510.95 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-13,284,012.31 |
2,320,460.35 |
1,184,739.26 |
-1,431,304.36 |
| 其中：股票投资收益 |
527,918.03 |
-1,008,947.96 |
24,912.43 |
193,915.93 |
| 基金投资收益 |
-13,818,519.46 |
3,329,344.31 |
1,159,762.83 |
-1,625,220.29 |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
6,589.12 |
64.00 |
64.00 |
- |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-11,939,663.91 |
-13,915,870.79 |
12,327,845.61 |
-1,528,143.23 |
| 其他收入 |
364,539.61 |
457,032.94 |
54,836.61 |
48,573.21 |
| 费用 |
648,132.52 |
438,015.25 |
95,060.11 |
43,753.28 |
| 管理人报酬 |
24,862.24 |
15,904.19 |
3,756.20 |
2,283.29 |
| 基金托管费 |
8,287.42 |
5,301.37 |
1,252.02 |
761.06 |
| 销售服务费 |
543,082.56 |
334,299.60 |
66,691.13 |
34,289.79 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
71,900.30 |
70,234.01 |
19,180.18 |
6,419.14 |
| 利润总额 |
-25,440,715.81 |
-11,531,639.77 |
13,482,461.61 |
-2,948,116.71 |
微信公众号
证券之星APP
基本资料
